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Objective: The aim of this study was to evaluate the effects of aminoguanidine treatment on dermal extracellular matrix protein 
expression and collagen structure in a diabetic rat model. 
Methods: Twelve Wistar Albino male rats were induced diabetes by streptozosin. Six rats were given aminoguanidine in drinking water; 
remaining 6 rats were followed as diabetic controls. Additional six rats were followed as healthy controls. After an 8-week follow-up 
period skin samples obtained and evaluated for light microscopy and immunohistochemistry for collagen IV and TGF- β. 
Results: Light microscopy revealed increase in basement membrane thickness, dermal edema, vascular membrane thickness, increase in 
endothelial proliferation and perivascular degeneration in diabetic rats. Immunohistochemical staining displayed reduction in collagen IV 
and TGF- β in diabetic group compared to others. All these changes were ameliorated with aminoguanidine treatment. 
Conclusion: This study confirms microscopic abnormalities in clinically normal skin of diabetics that can be prevented with 
aminoguanidine treatment. 
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DİYABETİK SIÇAN MODELİNDE AMİNOGUANİDİN TEDAVİSİNİN EKSTRASELÜLER 
MATRİKS PROTEİN EKSPRESYONU VE KOLLOJEN YAPISINA ETKİSİ 
ÖZET 
 
Amaç: Diyabete bağlı cilt değişiklikleri klinik olarak normal durumdayken başlamaktadır ve metabolik kontrolle doğru orantılıdır. Bu 
çalışmanın amacı diyabetik sıçan modelinde aminoguanidin tedavisinin ekstraselüler matriks protein ekspresyonu ve kollojen yapısına 
etkisini incelemektir.  
 
Yöntem: Bu amaçla streptozosin ile diyabet oluşturulmuş 12 sıçandan 6 tanesine içme suyuna aminoguanidin eklenerek, diğerleri ise 
ilaçsız olarak 8 hafta boyunca izlendi. Altı sıçan da sağlıklı kontrol olarak takip edildi. Takip süresi sonunda cilt dokuları alınarak 
incelendi. 
 
Bulgular: Işık mikroskopisinde diyabetik sıçanlarda bazal membranda kalınlaşma, dermal ödem, vasküler membran kalınlaşması, 
endotel proliferasyonu ve perivasküler dejenerasyon gözlendi. İmmünhistokimyasl boyamada kollojen IV ve TGF-β’da azalma görüldü. 
Tüm bu değişikliklerin aminoguanidin tedavisi ile oluşmadığı izlendi.  
 
Sonuç: Bu çalışma diyabetin klinik olarak normal görülen ciltte mikroskopik bozukluklar oluşturduğunu doğrulamaktadır. 
Aminoguanidin tedavisi cilt değişikliklerinin gelişimini engellemektedir. 
 




Studies have demonstrated microscopic 
abnormalities in the clinically normal skin of 
diabetic patients 1. Histological changes in 
diabetic skin are attributed to metabolic changes 
in diabetes. Advanced  glycosylation of  long 
lived structural proteins of skin found to be 
associated with structural and functional changes 
in diabetes 2. Advanced glycation end products 
(AGEs) have been reported to accumulate in the 
dermal skin and modulated cell function of dermal 
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fibroblasts 3. Collagen, which is the most 
abundant protein of skin, was shown affected 
from non-enzymatic glycosylation process. 
Glycosylated skin collagen was found to correlate 
with duration of diabetes and to various degrees 
with the severity of retinopathy and nephropathy 
in patients with type 1 diabetes 2, 4. 
 
Other extracellular matrix components are 
involved in the pathogenesis of skin changes in 
diabetes. Decreased glycosaminoglycan content 5, 
ratio of fibronectin to collagen produced by skin 
fibroblasts were reported 6. Some of the growth 
factors are known to involve in the wound healing 
process in diabetes. 
 
Inhibition of advanced glycation end products 
with aminoguanidine was shown to ameliorate the 
dermal lesions in diabetic rats 7. 
 
The aim of this study was to evaluate the effects 
of aminoguanidine treatment on dermal 
extracellular matrix protein expression and 




All animal procedures were in accordance with 
the declaration of Helsinki and the guide for the 
care and use of laboratory animals. Study protocol 
was approved by the local ethic committee of 
Marmara University. 
 
Twelve, 10 weeks old Wistar Albino male rats 
(180-200 g) were induced diabetes by 
streptozotocin (STZ, Sigma Mo, USA) injection 
(65 mg/kg, ip). One week after STZ injection 
diabetes was confirmed demonstrating that the 
overnight fasting blood glucose was more than 
250 mg/dL. Six rats were given aminoguanidine 
bicarbonate (AG, Sigma, 1g/L/d), (group DAG) in 
drinking water add libitum, remaining 6 rats were 
followed as diabetic controls (group D) and only 
given tap water. Six rats were included as healthy 
controls (group H). During the experiments, 
animals were housed one per cage, maintained 
under controlled environmental conditions (12-h 
light/dark cycle, temperature ∼21ºC), and 
provided with standard rat chow and water add 
libitum. All groups were followed 8 weeks. 
 
At the end of the 8 week period skin samples from 





The samples were fixed in 10% buffered formalin 
for light microscopic examination. After fixation 
they embedded in paraffin. Sections 5-mm thick of 
paraffin embedded tissues were mounted on glass 
slides and stained with hematoxylin and eosin and 
alcian blue in critical electrolyte to determine 
glycosaminoglycan deposition throughout the skin8. 
 
Using masked slides under the microscope at X20 
to X400 magnifications epidermal, basement 
membrane thickness, dermal edema, small 
vascular structure, PAS accumulation, endothelial 
proliferation and perivascular infiltration were 
evaluated by two blinded investigators and 




Briefly, sections (5mm) of the formalin fixed and 
paraffin embedded wound samples were placed 
onto 3-aminopropyltriethoxysilane coated slides 
(Sigma, St Louis, MO), deparaffinised and 
rehydrated. Endogenous peroxidase activity was 
blocked by further pretreatment with 1% H2O2/ 
methanol for 20 minutes at room temperature. The 
sections were incubated with pepsin (1 mg/mL in 
0.01 N HCl ) for 60 minutes at 37ºC and 
subsequently rinsed 2-3 changes of distillated 
water and tris buffer saline pH 7.0 for 10 minutes. 
The sections were incubated with polyclonal goat 
anti-bovine antibody / anti-mouse collagen IV and 
TGF-b anti-mouse primary antibodies obtained 
from Novo Castra Laboratories U.K. 
 
Peroxidase conjugates were subsequently 
localized using diaminobenzidine 
tetrahydrochloride (DAB) as a chromogen 
(Zymed Lab Inc. San Francisco, CA). 
 
A semi quantitative scale adapted from O’Brien et 
al.9 was used for immunohistochemical evaluation 
by two pathologists in blind way. 
 
Stained sections was graded as 0 = absent 
staining, 1+ = weak staining (<20% tissue 
stained), 2+ = moderate staining (20-50% tissue 










Serum glucose measurements were 88 ± 9, 
291± 91, 281 ± 153 mg /dl for group H, D and 
DAG, respectively. 
 
Light microscopic evaluation of skin samples 
are shown in Figure 1. 
 
Pathologic changes were observed in diabetic 
control group. Increased basement membrane 
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thickness, dermal edema, vascular membrane 
thickness, accumulation of PAS positive material, 
increased endothelial proliferation, perivascular 
degeneration were prominent changes in diabetic 
controls compared with other groups (Fig. 1A). 
AG treated diabetic rats have less edema and 
perivascular degeneration than diabetic controls 
(Fig. 1B). No pathologic changes were observed 
in the skins of healthy rats (Fig. 1C). 
Prominent changes were observed in collagen 
fibers in diabetic rats. Collagen fibers were 
partially atrophic, swollen and fused to make 
dense collagen bundles sometimes associated with 
neutrophilic infiltration. Almost all of these  
findings are ameliorated in aminoguanidine 
treated diabetic rats. No significant change was 
observed in healthy rat skin. 
Immunohistichemical staining of skin, collagen 
IV was reduced in diabetic controls (Fig. 2A) 
compared with group H (Fig. 2B) and DAG (Fig. 
2C). 
 
TGF – β expression was reduced in diabetic rat 
skins (Fig. 3A). AG treated diabetic rats (Fig. 3C) 







































Fig. 2: Collagen IV staining of intact skins of healthy (A), diabetic control (B) and aminoguanidine treated diabetic rats (C) H-Ex 
200 
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This study confirms the previous studies that 
observed remarkable histological changes in intact 
diabetic skin. 
 
In clinical studies scleroderma like changes 
observed in clinically normal skin of type 1 
diabetic patient 10. Dermal histopathology in 
diabetic rats resembles with clinical observations. 
Thickened dermal blood vessel walls, 
multilaminated basement membrane, degenerative 
collagen fibers reported in diabetic rat models 1,6. 
 
Collagen, which is the major fibrous element of 
the skin, was edematous, irregular and fused as 
bundles in non treated diabetic rats. All those 
changes ameliorated with aminoguanidine 
treatment. Prominent finding was the reduced, 
atrophic, and edematous collagen fibers. In AG 
treated rats collagen fibers were more regular, less 
edematous and atrophic and increased compared 
to diabetic controls. Total mass, synthesis of skin 
collagen found to diminish in diabetic rats and 
attributed to the delayed and depressed wound 
healing 6,11. These results suggest that the 
histological changes in diabetic skin were caused 
by metabolic aberrations such as non-enzymatic 
glycosylation, peculiar to diabetes. 
Collagen IV an extracellular matrix protein, was 
reduced in non-treated diabetic rats and increased 
with aminoguanidine treatment. 
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